Knott David M Jr
Top Portfolio Positions
76 positions ·
$127,435,751 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| APO |
Apollo Global Management, Inc.
Financial Services
|
225,000 | $25,069,500 | 19.67% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
422,000 | $9,857,920 | 7.74% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
90,000 | $6,683,400 | 5.24% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
63,000 | $6,640,200 | 5.21% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
1,060,000 | $6,148,000 | 4.82% | |
| JPM |
Jpmorgan Chase & Co
Financial Services
|
19,477 | $5,729,354 | 4.50% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
1,600,000 | $5,616,000 | 4.41% | |
| ALKS |
Alkermes plc.
Healthcare
|
120,000 | $4,243,200 | 3.33% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
140,633 | $4,178,206 | 3.28% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
104,000 | $4,002,960 | 3.14% |
Portfolio Trend
18 quarters · across all stocks
Holdings in SNDX
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,857,920 | 422,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,719,150 | 415,000 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $6,584,780 | 428,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,303,765 | 352,778 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,572,480 | 128,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,692,160 | 128,000 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,351,272 | 122,144 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,131,547 | 103,826 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,558,305 | 65,475 | Shares | Defined | 2024-05-14 | |
| No 13F history on record for this holder in this stock. | ||||||